{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:34:53Z","timestamp":1784244893105,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.carrev.2023.04.020","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T20:27:00Z","timestamp":1682800020000},"page":"52-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)"],"prefix":"10.1016","volume":"55","author":[{"given":"Leonardo C.","family":"Clavijo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongkyu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Shavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2023.04.020_bb0005","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","volume":"124","author":"Rooke","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.04.020_bb0010","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.04.020_bb0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","article-title":"The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease","volume":"45","author":"Feringa","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2023.04.020_bb0020","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","article-title":"Statin therapy improves cardiovascular outcome of patients with peripheral artery disease","volume":"25","author":"Schillinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.04.020_bb0025","series-title":"Proceedings of the 7th Annual Meeting of the Mediterranean League of Angiology and Vascular Surgery, March 22-25 1996, Limassol, Cyprus","first-page":"73","article-title":"Lipid lowering drugs in the treatment of peripheral arterial disease of the lower limbs: results of the SISOPAD (Simvastatin Italian Study on Peripheral Arterial Disease)","author":"Novo","year":"1996"},{"key":"10.1016\/j.carrev.2023.04.020_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(03)00010-X","article-title":"Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patient with peripheral vascular disease","volume":"114","author":"Mondillo","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2023.04.020_bb0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9149(03)00833-6","article-title":"Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment","volume":"92","author":"Aronow","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.04.020_bb0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2005.10.052","article-title":"Statin use and functional decline in patients with and without peripheral arterial disease","volume":"47","author":"Giri","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2023.04.020_bb0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial diseases and other high-risk patients","volume":"45","author":"Heart Protection Study (HPS) Collaborative Study","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2023.04.020_bb0050","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"NEJM"},{"key":"10.1016\/j.carrev.2023.04.020_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.04.020_bb0060","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM199010043231404","article-title":"Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the program on the surgical control of the hyperlipidemias (POSCH)","volume":"323","author":"Buchwald","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2023.04.020_bb0065","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2005.10.052","article-title":"Statin use and functional decline in patients with and without peripheral arterial disease","volume":"47","author":"Giri","year":"2006","journal-title":"JACC"},{"key":"10.1016\/j.carrev.2023.04.020_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9149(97)00904-1","article-title":"Effect of simvastatin on ischemic signs and symptoms in the scandinavian simvastatin survival study (4S)","volume":"81","author":"Pedersen","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.04.020_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(03)00010-X","article-title":"Effect of simvastatin on walking performance an symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease","volume":"114","author":"Mondillo","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2023.04.020_bb0080","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9149(03)00833-6","article-title":"Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and one year after treatment","volume":"92","author":"Aronow","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.04.020_bb0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.04.020_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2017.10.072","article-title":"Platelet-derived MRP-14 induces monocyte activation in patients with symptomatic peripheral artery disease","volume":"71","author":"Dann","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:26:40Z","timestamp":1761560800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838923001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":18,"alternative-id":["S1553838923001628"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.04.020","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}